Over-the-counter MTP Pills and Its Impact on Women’s Health

被引：7

作者：

Sarojini ^{[1
]}

Ashakiran T.R. ^{[2
]}

Bhanu B.T. ^{[3
]}

Radhika ^{[4
]}

机构：

[1] Department of OBG, BMCRI, No. 55, 11th Main, Opposite Cluny Convent, Malleshwaram, Bangalore

[2] Department of OBG, BMCRI, No. 620, A4, Krishna Block, National Games Village, Koramangala, Bangalore

[3] Department of OBG, BMCRI, No. 20, Shravya, 40 Feet Road, 7th Cross, Manjunathanagar, Bangalore

[4] Department of OBG, BMCRI, No. 617, B4, Sharavathi Block, National Games Village, Koramangala, Bangalore

来源：

The Journal of Obstetrics and Gynecology of India | 2017年 / 67卷 / 1期

关键词：

Blood transfusions; Incomplete abortion; MTP pills; Over the counter; Rupture uterus;

D O I：

10.1007/s13224-016-0916-9

中图分类号：

学科分类号：

摘要：

Objectives: To study the complications and consequences including maternal morbidity and mortality following indiscriminate self-consumption of abortion pills reporting to a tertiary care center. Methodology: This is an observational study conducted at Vanivilas hospital between January 2012 to December 2013 for 24 months. After applying inclusion and exclusion criteria, 104 women were studied with respect to period of gestation, parity, clinical features at presentation and management in the institution. An analysis of maternal morbidity and mortality was done with respect to surgical interventions, ICU admissions, need for blood transfusions and maternal deaths. Observations and results: In this study, there were 75 (72.2 %) cases of incomplete abortion, 10 (9.6 %) cases of missed abortion, 2 (1.9 %) cases of ruptured ectopic and 2 (1.9 %) cases of rupture uterus. Seventy-eight (75 %) cases received blood transfusion, 7 (6.7 %) were admitted to ICU, and 2 (1.9 %) developed acute kidney injury. There were 2 (1.9 %) maternal deaths in the study group. Conclusion: This study shows urgent need for legislation and restriction of drugs used for medical termination of pregnancy. Drugs should be made available via health care facilities under supervision to reduce maternal mortality and morbidity due to indiscriminate use of these pills. © 2016, Federation of Obstetric & Gynecological Societies of India.

引用

页码：37 / 41

页数：4

共 12 条

[1]

Cunningham F.G., Leveno K.J., Bloom S.L., Haulh J.C., Gilstrap L.C., Wenstrom K.D., Williams Textbook of Obstetrics, 24th ed, New York: McGraw-Hill, 2014, pp. 215-235

[2]

Chaudhari S.K., Pregnancy termination, Practice of Fertility Control a Comprehensive Manual, 7th ed, pp. 237-263

[3]

Frequently asked clinical questions about medical abortion, (2006)

[4]

Ellertson C., Waldman S.N., The Mifepristone–Misoprostol regimen for early medical abortion, Curr Women Health Rep, 1, pp. 184-190, (2001)

[5]

Thaker R.V., Deliwala K.J., Shah P.T., Self medication of abortion pill: women’s Health in Jeopardy, NHL J Med Sci., 3, 1, pp. 26-31, (2014)

[6]

Kapur K., Joneja G.S., Biswas M., Medical abortion—an alternative to surgical abortion, MJAFI, 62, pp. 351-353, (2006)

[7]

Coyaji K., Early medical abortion in India: three studies and their implications for abortion services, J Am Med Womens Assoc, 55, pp. 191-194, (2000)

[8]

Bajwa S.K., Bajwa S.J.S., Ghai G.K., Singh N., Singh A., Goraya S.P.S., Medical abortion: is it a blessing or curse for the developing nations?, Sri Lanka J Obstet Gynaecol, 33, 3, pp. 84-90, (2011)

[9]

Tran N.T., Jang M.C., Choe Y.S., Et al., Feasibility, efficacy, safety and acceptability of Mifepristone–Misoprostol for medical abortion in the Democratic People’s Republic of Korea, Int J Gynecol Obstet, 109, 3, pp. 209-212, (2010)

[10]

Debnath J., Gulati S., Mathur A., Et al., Ectopic pregnancy in the era of medical abortion: are we ready for it? Spectrum of sonographic findings and our experience in a tertiary care service hospital of India, J Obstet Gynecol India, 66, 6, pp. 388-393, (2013)

← 1 2 →